Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Otelixizumab [USAN:INN]
RN: 881191-44-2
UNII: I5HF2X04PB

Note

  • An antidiabetic agent in clinical trials (2010).

Molecular Formula

  • C6448-H9954-N1718-O2016-S42
 

Classification Codes

  • Psoriasis
  • Type 1 Diabetes
  • Type 1 Diabetes and Psoriasis
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Otelixizumab [USAN:INN]

Synonyms

  • ChAglyCD3
  • Otelixizumab
  • TRX4
  • Unglycosylated immunoglobulin G1, anti-(human CD3 epsilon chain) humanized rat monoclonal YTH12.5; gamma 1 heavy chain
  • Unglycosylated immunoglobulin G1, anti-(human CD3 epsilon chain) humanized rat monoclonal YTH12.5; gamma 1 heavy chain (humanized VH (Homo sapiens FR/Rattus norvegicus CDR)-(297-alanine) Homo sapiens IGHG1) (222-214)-disulfide with chimeric lambda light chain (Rattus norvegicus VL/Homo sapiens IGLC2); (228-228':231-231')-bisdisulfide dimer
  • UNII-I5HF2X04PB

Systematic Name

  • Immunoglobulin G1, anti-(human CD3 (antigen)) (human-rat monoclonal heavy chain), disulfide with human-rat monoclonal lambda-chain, dimer

Registry Numbers

CAS Registry Number

  • 881191-44-2

FDA UNII

  • I5HF2X04PB

System Generated Number

  • 0881191442